Annual Lung SPORE Workshop (Abstract Submission): Submission #67

Submission information
Submission Number: 67
Submission ID: 110626
Submission UUID: f2f38073-6cf0-4df5-9645-0a236130106c

Created: Mon, 03/11/2024 - 13:59
Completed: Mon, 03/11/2024 - 14:47
Changed: Mon, 05/06/2024 - 10:59

Remote IP address: 10.208.28.228
Submitted by: Anonymous
Language: English

Is draft: No
Abstract Submission
-------------------
First Name: Mustafa
Last Name: Al-Dulaimi
Email: mustafa_al-dulaimi@dfci.harvard.edu
Phone: 12087180181
Affiliation - Presenter: Dana-Farber Cancer Institute
Abstract Title:
CDK8/19 Co-inhibition Enhances Osimertinib Efficacy in EGFR Mutant Non-Small Cell Lung Cancers (NSCLC)

First Author
------------
First Author First Name: Mustafa
First Author Last Name: Al-Dulaimi
Affiliation: DFCI

Additional Authors
------------------
List of Additional Authors:
- First Name: Antja-Voy
  Last Name: Hartley
  Affiliation: DFCI
- First Name: Simon
  Last Name: Baldacci
  Affiliation: DFCI
- First Name: Matthew 
  Last Name: Booker
  Affiliation: DFCI
- First Name:  Nathanael 
  Last Name: Gray
  Affiliation: Stanford Cancer Institute
- First Name: Michael
  Last Name: Tolsturokov
  Affiliation: DFCI
- First Name: Pasi
  Last Name: Janne
  Affiliation: DFCI


Select a Session Topic: Session 6: Cancer Biology
Upload Abstract: https://events.cancer.gov/sites/default/files/webform/lung_spore_investigator_abstract/110626/ABRCMS%202023%20Abstract_MA%209-7-23.docx
Special Characters Included?: No

Abstract Review Status: Approved to be a Poster Presenter
Poster Uploaded: {Empty}
Poster Submission
-----------------
Upload Poster: {Empty}